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ABSTRACT 
The discovery of Helicobacter pylori in the human stomach by Professor W. Jaworski has encouraged many scientists to study these 
bacteria, their characteristics, and their effect on human health. In 1982, Marshall and Warren showed experimentally that H. pylori 
infection is responsible for human gastritis. The pathogenic urease found in H. pylori causes infection not only in the stomach, but 
also in the duodenum, uterus, and urinary tract, among others. To determine the efficacy and potency of newly synthesized 
compounds in treating H. pylori infection, docking studies were performed with the 1E9y protein. During these studies, the Arg338, 
Ala365, Asn168, and Hie221 amino acids were observed to actively participate in bond formation with the studied compounds. In 
this series of compounds, only the R2 –substituted group is responsible for the observed biological activity. In this study, the results 
have been revaluated with MD simulations, in which the potency of the compounds was assessed by the percent contribution of 
hydrogen bonds at the end of the simulation. To calculate the free energy, the present study employs MMGBSA and finds the 
deviation of the RMSD value. 
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INTRODUCTION:  





. H. pylori, 
both genotypically and phenotypically, are highly 
heterogeneous bacteria that can survive in highly 
adverse environments 
3
. In 1980, Marshall and Warren
4
 
discovered that H. pylori infection is the primary cause 
of gastric cancer, a discovery for which both scientists 
were awarded the Nobel Prize in Physiology or 
Medicine. The author, motivated by this discovery, has 
become interested in studying the carcinogenic 
properties of H. pylori. In addition to gastric cancer, H. 
pylori have been found to cause gastritis, peptic ulcers, 
and duodenal ulcers.  
N, N’-disubstituted thiourea, a basic and important 
derivative of thiourea, can be found in either white 
crystalline leaflets or grey powder. Due to the 
remarkable number of its potential derivatives, N, N’-
disubstituted thiourea has become pharmacologically 
and industrially significant and continues to be an 
essential compound for future drug development. 
To determine the pharmacological action of these 
compounds, each must go through the drug design 
process, of which molecular modelling is an essential 
step. Though it is the least time-consuming approach to 
molecular modelling, docking studies, falling within the 
scope of computational quantum chemistry, provide 
sufficient explanatory power for study needs and 
generate results (molecular visualization and graphics) 
that are easily interpreted. For the newly synthesized 
series, docking had to be done initially to determine the 
protein-ligand binding pose, the orientation of the ligand 
on the protein binding site, the bonds that form between 
the protein and the ligand, the contributions to bond 
formation made by hydrophobic and polar regions of the 
active site. After for checking the results for accuracy, 
MD-simulations (advanced docking) were performed to 
determine the stability and consistency of each bond via 
its duration as determined from the snapshots. Although 
MD simulations are time-consuming and costly, their 
use remains widely accepted and suitable. As long as 
computer power and advanced quantum algorithms 
continue to improve, the future of computer-aided drug 
modelling seems to be very promising, though study 
should overcome the limitations of the simulations 
themselves. In particular, simulations are useful for 
finding the RMSD, RMSF, and Gyration Radii. 
Following the simulation, MMGBSA, an attractive 
approach used to revaluate the results obtained by virtual 
screening or docking, is used to calculate the binding 
free energy between the protein and the ligand. 
MATERIAL AND METHODS: 
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Structures of compound of Reported series (Table 1) 
was draw using ChemSketch software, thereafter all 
structure were optimized. All proteins were downloaded 
from PDB database and processed with Schrodinger 
software. Docking was carried by using Extra Precision 
Glide module and then MMGBSA studies were 
performed. MD simulation was performed with 
Desmond software utility. 
RESULTS AND DISCUSSION: 
Active site: Within each protein, there is a specific 
active space, called the binding site, which is responsible 
for attaching and fitting incoming ligands. Cytosolic 
urease, a Ni
2+
-containing enzyme, is found in H. pylori. 
Structurally, each protein consists of a regular, precise, 
and systematic pattern of amino acids, forming by two 
chains, A and B, in which the α and β sub-units are 
present. In α sub-unit, there exists a catalytic cavity in 
which the two ligands Ni and HAE are found attached 
with a coordinated bond. The structural arrangement of 
ligands, both their geometry and orientation, makes the 
site suitable to bind incoming ligands.  
Docking Studies: To determine the potency of the 
selected compounds and find the combinations that are 
most effective as urease inhibitors, three different 
crystalline proteins, 1E9Y, 4UBP, and 4AC7, were 
imported from PDB into the Schrödinger glide module. 
Once the proteins have been imported, the XP glide 
docking process is applied. Compounds are selected 
randomly, such that some have an experimental IC50 
close to that of standard Thiourea while others have an 
experimental IC50 that differs significantly from the 
standard. Compounds 2, 24, 30, and 37 are selected for 
docking, which was performed with each of the three 
proteins mentioned above (Table 2). The docking score 
for each compound-protein pair was recorded and 
analysed. The first best dock score was determined by 
docking the compounds with 1E9Y. To ensure the 
accuracy of the results, the RMSD for each pair of 
compounds and proteins was calculated by 
superimposing the initial 3D structure of the ligand and 
the docked pose. The average RMSD was then 
calculated, from which the minimum deviation was 
found to be when compounds were docked with 1E9Y. 
Thus, the 1E9Y protein was selected for further detailed 
study, from which the docking results for the reported 
series were found.  
In Table 3, the XP glide score, docking score, interacting 
amino acids, and hydrogen bonds are shown. The three 
compounds with the best dock score (when docked with 
1E9Y) and the best experimental IC50 have been 
selected for detailed analysis. Compound 24 presents the 
best glide score due to its impressive affinity, perfect 
bonding, and favourable orientation. The pyridine ring in 
compound 24 enters the active site cavity, in which 
ring’s nitrogen atom forms a bond with the polar portion 
of the cavity. Nitrogen, [N···HN
+
], makes a side chain 
H-bond with the Hie221 amino acid. Similarly, the ring 




] and [Pi-Pi stackingC···N-H] 
bonds with the Arg338 amino acid. Additionally, the NH 
group of thiourea forms a backbone hydrogen bond 
[NH···O=C
-
] with Ala338, keeping the compound inside 
the cavity. The compound’s phenyl ring was found to be 
oriented towards the mouth of the cavity, but no bond 
was formed. 
In the case of compound 2, which has the second best 
dock score, the phenyl ring, representing the R
2
-
substituted group, enters the cavity. For this compound, 





] and [Pi-Pi stacking···C-N-H] bonds with 
Arg338. The ring could not fit into the cavity due to the 
inability of its chlorine group to form a bond. The NH 
group of thiourea also forms a backbone hydrogen bond 
[NH···O=C-] with Ala365. 
Compound 6, which has the next best dock score, enters 
the cavity primarily vertically, though tilted slightly 
towards the inner side. The compound’s meth-oxy-
phenyl ring reaches deep within the cavity, in which the 
oxy- group makes a side chain hydrogen bond [O---





] bond with Hie322, and the NH 
group of thiourea forms a backbone hydrogen bond 
[NH···O=C
-
] with Arg168. The compound’s second 
chloro-phenyl ring is oriented away from the cavity 
mouth, preventing it from participating in bond 
formation. 
For compound 30 (Figure 1), which was found to have 
the best IC50, the complete pyridine ring reaches deep 





Pi stacking···C-N-H] bonds with Arg338. As before, the 
NH group of thiourea also forms a backbone hydrogen 
bond [NH···O=C-] with Ala365. All bonds conveniently 
keep the compound in the cavity. 
Simulation Studies: Over the past decade, 
computational methods have proven to be instrumental 
to the field of biochemical and drug modelling, allowing 
scientists to investigate protein-ligand companionship at 
the atomic level. In this sense, computational 
simulations have acted as a bridge between the 
microscopic world observed in the laboratory and the 
microscopic length and time scales provided 
computationally. Fundamentally, MD simulations are 
merely statistical mechanics, showings all protein-ligand 
contacts and their stability through an impressive pattern 
found on each snapshot. 
Four compounds, 30, 24, 6, and 2, were selected for 
detailed study according to factors such as biological 
activity, docking score, and free energy. Figure 3 shows 
that the ligand-ligand RMSD for each compound is 0.96, 
1.61, 0.90 and 0.82, respectively, indicating that no more 
changes in orientation were observed after binding.  
For compound 30 (Figure 2), the three bonds were 
formed primarily through the water bridge, in which 
only the nitrogen atom of the pyridine ring was seen to 
participate in bond formation. 80% of the bonds with 
His138 are preserved, 32% of the bonds with Asn168 
are preserved, and 40% of the bonds with Ser363 are 
preserved. Although Ala365 and Arg338 are also seen to 
be participating in bond formation at the beginning of 
the docking simulation, these bonds had disappeared by 
the last snapshot. 
Similarly, only one water bridge formed between 
compound 24 and Thr251, of which 35% was preserved. 
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The nitrogen atom in the pyridine ring participated in 
bond formation. For compound 6, one hydrogen bond 
formed with Asn168 in the starting snapshot but 
disappeared before the final snapshot. In compound 2, at 
the beginning of the simulation, compound 2 formed two 
hydrogen bonds with Arg338 and Ala365. Later in the 
simulation, approximately half (57%) of the bonds with 
Ala169 were preserved. 
In short, compound 30 was found to be the most 
biologically active and shows stable bond interactions 
throughout the simulation. To this end, the analysis 
presented in this study supports the experimental results. 
Compound 24 did not show biological activity but 
displayed the best result during docking. Upon re-
examination via simulation, bonds were preserved up to 
35%. This result shows that the bioactivity of compound 
24 depends only on the behavior of the hydrogen bond. 
If the R group is replaced by an activating or electron-
donating group, the potency may be improved. 
Similarly, compound 6, which displays the minimum 
free binding energy in MMGBSA, did not preserve its 
potency for the duration of the simulation. This result is 
comparable to the manner in which compound 2 
displayed the second-best dock score, but did not 
preserve efficacy through the end of the simulation. 
Free Energy Studies: MMGBSA was carried out as a 
post-scoring approach for the reported series. The 
various energies derived in the course of this study are 
listed in Table 4 to this end; the present study provides a 
valuable correlation between the experimentally 
determined activity of a compound and the activity 
predicted via docking. 
The calculated free binding energies of the N, N’-
disubstituted thiourea compounds range from -4.7 to -
30.83. According to the energies obtained from this 
analysis, the primary contributions to bond formation are 
made by the Van der Waals and non-polar solvation 
energies (∆GsolSA). Conversely, the polar solvation 
(∆GsolGB) and Coulomb energies oppose bond formation. 
The data show that compound 30 presents an MMGBSA 
term of -30.83k/Cal in addition to its excellent 
experimentally-obtained activity. Thus, there is a high 
correlation between the values obtained via different 
approaches. The polar solvation energy term, which 
strongly opposes bond formation, should positive per the 
table. As such, the value obtained for compound 30 was 
65.42 k/Cal; the overall range is from 21.63 to 65.42 
k/cal. 
As mentioned above, the Coulomb energy term also 
strongly opposes bond-formation. In this study, 
however, compound 24 was found to have a coulomb 
energy of -2.54 k/Cal despite its excellent docking 
scores. Contrarily, the experimental data show that this 
compound was not biologically active. 
The other contributory energies, Van der Waals and bind 
lipo or ∆solSA, were found to have energies that range 
from -27.7 k/Cal to -42.23 k/Cal, and -6.73 k/Cal to-
14.90 k/Cal respectively. 
CONCLUSION: 
In this manuscript, the ligand-protein docking pose, their 
geometrical orientation, constituent bonding 
interactions, and binding free energy were discussed. 
Each method was performed separately, step by step, 
using different modules of Schrödinger and 
subsequently tested. MD simulations were used to 
determine many of the details that were seen in our 
initial studies, allowing for the examination of processes 
that experimental methods have been unable to study. In 
the field of drug modeling, further research regarding the 
development of advanced forms of quantum-virtual 
methods may help in the search for and discovery of 
novel, potent, and efficacious pharmaceutical agents. 
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